期刊文献+

2型糖尿病心脏Tei指数与B型氨基端利钠肽原和糖化血红蛋白的关系及联合预测主要不良心血管事件的价值 被引量:6

Relationship between cardiac Tei index and plasma amino terminal brain natriuretic peptide precursor, glycosylated hemoglobin in type 2 diabetes mellitus and its combined prediction value for major adverse cardiovascular events
原文传递
导出
摘要 目的 探讨2型糖尿病心脏Tei指数与B型氨基端利钠肽原(NT-proBNP)和糖化血红蛋白(HbA1c)的关系及联合预测主要不良心血管事件(MACE)的价值.方法 回顾分析2015年3月至2017年10月收治的160例2型糖尿病患者的临床资料.根据患者是否发生MACE分为MACE组(45例)和非MACE组(115例).对比分析两组的临床资料,并分析心脏Tei指数与NT-proBNP和HbA1c的关系,采用Logistic回归分析影响2型糖尿病患者发生MACE的危险因素.结果 MACE组收缩压、舒张压明显低于非MACE组[(109.10±14.53)mmHg(1 mmHg=0.133 kPa)比(120.76±18.74)mmHg和(64.29±9.82)mmHg比(73.58±12.11)mmHg],心率、Killip等级〉Ⅱ级率、心脏Tei指数和NT-proBNP明显高于非MACE组[(77.56±13.36)次/min比(71.68±11.39)次/min、28.89%(13/45)比2.61%(3/115)、0.63±0.12比0.52±0.08和(1193.20±145.69)μg/L比(823.87±89.22)μg/L],差异有统计学意义(P〈0.01).Pearson相关性分析结果显示,心脏Tei指数与NT-proBNP和HbA1c均呈正相关(r=0.817、0.793,P〈0.05);NT-proBNP与HbA1c也呈正相关(r=0.649,P〈0.05).Logistic回归分析结果显示,心脏Tei指数、NT-proBNP和HbA1c为2型糖尿病患者发生MACE的独立危险因素(OR=1.015、1.041和1.027,95%CI 1.005~0.213、1.012~7.036和1.002~4.222,P〈0.01或〈0.05).结论 2型糖尿病患者心脏Tei指数与NT-proBNP和HbA1c呈正相关,且均是MACE发生的危险因素,三者联合可有效预测MACE的发生、判定预后. Objective To investigate the relationship between cardiac Tei index and plasma amino terminal brain natriuretic peptide precursor (NT- proBNP), glycosylated hemoglobin (HbA1c) in type 2 diabetes mellitus and its value in predicting the occurrence of major adverse cardiovascular events (MACE). Methods The clinical data of 160 patients with type 2 diabetes mellitus from March 2015 to October 2017 were retrospectively analyzed. The patients were divided into MACE group (45 cases) and non-MACE group (115 cases). The clinical indexes were compared between 2 groups, and the relationship between cardiac Tei index and NT-proBNP, HbA1c was analyzed. Logistic regression analysis was used to analyze the risk factors of MACE in patients with type 2 diabetes mellitus. Results The systolic blood pressure and diastolic blood pressure in MACE group were significantly lower than those in non-MACE group: (109.10 ± 14.53) mmHg (1 mmHg = 0.133 kPa) vs. (120.76 ± 18.74) mmHg and (64.29 ± 9.82) mmHg vs. (73.58 ± 12.11) mmHg, the heart rate, Killip grade 〉 Ⅱ rate, cardiac Tei index and NT- proBNP were significantly higher than those in non- MACE group: (77.56 ± 13.36) times/min vs. (71.68 ± 11.39) times/min, 28.89% (13/45) vs. 2.61% (3/115), 0.63 ± 0.12 vs. 0.52 ± 0.08 and (1193.20 ± 145.69) μg/L vs. (823.87 ± 89.22) μg/L, and there were statistical difference (P〈0.01). Pearson regression analysis result showed that cardiac Tei index was positively correlated with NT- proBNP and HbA1c (r = 0.817 and 0.793, P 〈 0.05), and there was positive correlation between NT-proBNP and HbA1c (r = 0.649, P 〈 0.05). Logistic regression analysis result showed that cardiac Tei index, NT-proBNP and HbA1c were the independent risk factors of MACE in patients with type 2 diabetes mellitus (OR = 1.015, 1.041 and 1.027; 95% CI 1.005 to 0.213, 1.012 to 7.036 and 1.002 to 4.222; P〈0.01 or 〈0.05). Conclusions The cardiac Tei index has positive correlation with NT- proBNP and HbA1c in patients with type 2 diabetes mellitus, and both are risk factors for the occurrence of MACE. The combination of the 3 indexes can effectively predict the occurrence of MACE and assess the prognosis.
作者 文海清 郭娟 张萍 雷晓珍 Wen Haiqing;Guo Juan;Zhang Ping;Lei Xiaozhen(Department of Endocrinology,the Second People's Hospital of Xining,Xining 810003,China)
出处 《中国医师进修杂志》 2018年第9期829-832,847,共5页 Chinese Journal of Postgraduates of Medicine
关键词 糖尿病 2型 心血管疾病 血红蛋白A 糖基化 TEI指数 Diabetes mellitus type 2 Cardiovascular diseases Hemoglobin A glycosylated Tei index
  • 相关文献

参考文献11

二级参考文献122

  • 1曹雅旻,胡大一,王宏宇,吴彦.我国基层医院慢性心力衰竭药物治疗现状调查[J].中华内科杂志,2006,45(11):907-909. 被引量:72
  • 2无.血管紧张素转换酶抑制剂在心血管病中应用中国专家共识[J].中华心血管病杂志,2007,35(2):97-106. 被引量:130
  • 3杨慧霞.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中国实用妇科与产科杂志,2007,23(6):475-477. 被引量:363
  • 4Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey[J]. Eor Heart J, 2006, 27(21 ) :2573-2579.
  • 5Bartnik M, Ryd6n L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart [J]. Eur Heart J, 2004, 25(21 ) :1880-1890.
  • 6American Diabetes Association. Diagnosis and classification of diabetes mellitus [ J ]. Diabetes Care, 2010, 33 ( Suppl 1 ) :S62- S69.
  • 7International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes [J]. Diabetes Care, 2009, 32(7) :1327-1334.
  • 8World Health Organization. Use of glycated haemoglobin ( HbA1 c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation[ R]. Geneva: World Health Organization, 2011.
  • 9Ryd6n L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pro-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre- diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) [ J]. Eur Heart J, 2013, 34(39) :3035-3087.
  • 10Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[ J]. Diabet Med, 1998, 15 (7) :539-553.

共引文献227

同被引文献69

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部